Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples